Marko Jörg, Johanna E. Plehn, Kristina Friedland and Walter E. Müller* Pages 733 - 752 ( 20 )
Alzheimer’s disease (AD) is the most common progressive neurodegenerative disease. Today, AD affects millions of people worldwide and the number of AD cases will further increase with longer life expectancy. The AD brain is marked by severe neurodegeneration, such as the loss of synapses and neurons, atrophy and depletion of neurotransmitter systems, especially in the hippocampus and cerebral cortex. Recent findings highlight the important role of mitochondrial dysfunction and increased oxidative stress in the pathophysiology of late-onset alzheimer’s disease (LOAD). These alterations are not only observed in the brain of AD patients but also in the periphery. In this review, we discuss the potential role of elevated apoptosis, increased oxidative stress and mitochondrial dysfunction as peripheral markers for the detection of AD in blood cells e.g. lymphocytes. We evaluate recent findings regarding impaired mitochondrial function comprising mitochondrial respiration, reduced complex activities of the respiratory chain and altered Mitochondrial Membrane Potential (MMP) in lymphocytes as well as in neurons. Finally, we will question whether these mitochondrial parameters might be suitable as an early peripheral marker for the detection of LOAD but also for the transitional stage between normal aging and Dementia, “Mild Cognitive Impairment” (MCI).
Alzheimers disease, neurodegeneration, mitochondria, lymphocytes, brain, mitochondrial dysfunction, ROS, genetics.
Pharmacology and Toxicology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University, Mainz, Pharmacology and Toxicology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University, Mainz, Pharmacology and Toxicology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University, Mainz, Department of Pharmacology, Biocenter, Goethe University, Frankfurt